| For: |
Hao JH, Yu M, Li HK, Shi YR, Li Q, Hao XS. Inhibitory effect of antisense vascular endothelial growth factor RNA on the profile of hepatocellular carcinoma cell line |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i7/1140.htm |
| Number | Citing Articles |
| 1 |
Richard S Finn, Andrew X Zhu. Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Expert Review of Anticancer Therapy 2009; 9(4) doi: 10.1586/era.09.6
|
| 2 |
Derek Y. Chiang, Augusto Villanueva, Yujin Hoshida, Judit Peix, Philippa Newell, Beatriz Minguez, Amanda C. LeBlanc, Diana J. Donovan, Swan N. Thung, Manel Solé, Victoria Tovar, Clara Alsinet, Alex H. Ramos, Jordi Barretina, Sasan Roayaie, Myron Schwartz, Samuel Waxman, Jordi Bruix, Vincenzo Mazzaferro, Azra H. Ligon, Vesna Najfeld, Scott L. Friedman, William R. Sellers, Matthew Meyerson, Josep M. Llovet. Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma. Cancer Research 2008; 68(16) doi: 10.1158/0008-5472.CAN-08-0742
|
| 3 |
Esther Raskopf, Annabelle Vogt, Tilman Sauerbruch, Volker Schmitz. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. Journal of Hepatology 2008; 49(6) doi: 10.1016/j.jhep.2008.07.022
|